Efficacy of systemic therapies for moderate-to-severe psoriasis: a systematic review and meta-analysis of long-term treatment
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Efficacy of systemic therapies for moderate-to-severe psoriasis: a systematic review and meta-analysis of long-term treatment
Authors
Keywords
-
Journal
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
Volume 26, Issue 11, Pages 1331-1344
Publisher
Wiley
Online
2012-03-09
DOI
10.1111/j.1468-3083.2012.04492.x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Multicenter Open-Label Experience on the Response of Psoriasis to Adalimumab and Effect of Dose Escalation in Non-Responders: The Aphrodite Project
- (2017) G.A. Vena et al. INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY
- Prevalence of skin lesions and need for treatment in a cohort of 90 880 workers
- (2011) M. Augustin et al. BRITISH JOURNAL OF DERMATOLOGY
- Registerforschung in der Dermatologie
- (2011) S.J. Rustenbach et al. HAUTARZT
- S3-Leitlinie zur Therapie der Psoriasis vulgaris - Methodenreport
- (2011) Alexander Nast et al. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT
- Safety of treatment with biologics for psoriasis in daily practice: 5-year data
- (2011) P.P.M. van Lümig et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Definition of treatment goals for moderate to severe psoriasis: a European consensus
- (2010) U. Mrowietz et al. ARCHIVES OF DERMATOLOGICAL RESEARCH
- The Impact of Methodological Approaches for Presenting Long-Term Clinical Data on Estimates of Efficacy in Psoriasis Illustrated by Three-Year Treatment Data on Infliximab
- (2010) M. Papoutsaki et al. DERMATOLOGY
- Infliximab monotherapy in Japanese patients with moderate-to-severe plaque psoriasis and psoriatic arthritis. A randomized, double-blind, placebo-controlled multicenter trial
- (2010) Hideshi Torii et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- Responses to ustekinumab in the anti-TNF agent-naïve vs. anti-TNF agent-exposed patients with psoriasis vulgaris
- (2010) A. Clemmensen et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Combination of skin, joint and quality of life outcomes with etanercept in psoriasis and psoriatic arthritis in the PRESTA trial
- (2010) JC Prinz et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Psoriasis genetics: breaking the barrier
- (2010) Elisha D.O. Roberson et al. TRENDS IN GENETICS
- Efficacy and Safety of Etanercept in Psoriasis after Switching from Other Treatments
- (2009) Annamaria Mazzotta et al. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
- British Association of Dermatologists’ guidelines for biologic interventions for psoriasis 2009
- (2009) C.H. Smith et al. BRITISH JOURNAL OF DERMATOLOGY
- Ustekinumab improves health-related quality of life in patients with moderate-to-severe psoriasis: results from the PHOENIX 1 trial
- (2009) M. Lebwohl et al. BRITISH JOURNAL OF DERMATOLOGY
- Methotrexate versus traditional Chinese medicine in psoriasis: a randomized, placebo-controlled trial to determine efficacy, safety and quality of life
- (2009) S. G. Y. Ho et al. CLINICAL AND EXPERIMENTAL DERMATOLOGY
- Improvements in patient-reported outcomes in moderate-to-severe psoriasis patients receiving continuous or paused etanercept treatment over 54 weeks: the CRYSTEL study
- (2009) E Daudén et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- European S3-Guidelines on the systemic treatment of psoriasis vulgaris
- (2009) D Pathirana et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Combining etanercept and acitretin in the therapy of chronic plaque psoriasis: a 24-week, randomized, controlled, investigator-blinded pilot trial
- (2008) P. Gisondi et al. BRITISH JOURNAL OF DERMATOLOGY
- Infliximab improves health-related quality of life in the presence of comorbidities among patients with moderate-to-severe psoriasis
- (2008) S.R. Feldman et al. BRITISH JOURNAL OF DERMATOLOGY
- Efficacy and tolerability of biologic and nonbiologic systemic treatments for moderate-to-severe psoriasis: meta-analysis of randomized controlled trials
- (2008) J. Schmitt et al. BRITISH JOURNAL OF DERMATOLOGY
- Disease Severity, Quality of Life and Health Care in Plaque-Type Psoriasis: A Multicenter Cross-Sectional Study in Germany
- (2008) M. Augustin et al. DERMATOLOGY
- Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)
- (2008) Craig L Leonardi et al. LANCET
- Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2)
- (2008) Kim A Papp et al. LANCET
- Patient-Reported Outcomes and Health-Care Resource Utilization in Patients with Psoriasis Treated with Etanercept: Continuous versus Interrupted Treatment
- (2007) Joel M. Gelfand et al. VALUE IN HEALTH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now